FDA Inspection 1013147 - Haematologic Technologies, LLC dba Prolytix - May 11, 2017

Record Details

This FDA Inspection record concerns Haematologic Technologies, LLC dba Prolytix, with an inspection on May 11, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Haematologic Technologies, LLC dba Prolytix
Inspection Date: May 11, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · c6e6dd3e-5093-458a-9a69-6b09b1f005a4

Violation Codes1

21 CFR 211.194(a)(8)

Full citation text and observation details available on the Dashboard.